All patients were treated with the same triple antiemetic regimen containing aprepitant.A total of 165 chemotherapy-nave patients (52 FLOT recipients) were eligible to enter the study. At the end of day 5, "complete response" (primary efficacy endpoint) was achieved by 84.6%, 63.5%, and 61.5...
777PEvaluation of the introduction of primary G-CSF prophylaxis to the FLOT chemotherapy regimen 来自 ResearchGate 喜欢 0 阅读量: 11 作者:KM Crampton,J Wood,H Wong,M Mckay,A Madi 摘要: Background FLOT chemotherapy is a standard of care for patients with early gastric & gastroesophageal ...
Evaluation of the introduction of primary G-CSF prophylaxis to the FLOT chemotherapy regimenBackground FLOT chemotherapy is a standard of care for patients with early gastric & gastroesophageal junction adenocarcinoma: 4 cycles pre- and 4 post-surgery. It was introduced at the Clatterbridge Cancer ...
There is no preference for postoperative chemotherapy with the two common treatment regimens, FLOT and FOLFOX, in these patients. The aim of this study was to compare FOLFOX and FLOT regimens in perioperative chemotherapy in resectable GC based on pathological response and complications. Methods: ...